IRIS UniCatt

Rossi, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.281
AS - Asia 3.233
EU - Europa 2.833
SA - Sud America 519
Continente sconosciuto - Info sul continente non disponibili 170
AF - Africa 90
OC - Oceania 11
Totale 12.137
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.137
SG - Singapore 1.680
DE - Germania 717
CN - Cina 668
IT - Italia 579
SE - Svezia 449
BR - Brasile 423
FR - Francia 246
VN - Vietnam 230
UA - Ucraina 146
GB - Regno Unito 142
IE - Irlanda 130
PL - Polonia 123
IN - India 105
BD - Bangladesh 102
ID - Indonesia 88
HK - Hong Kong 77
FI - Finlandia 75
CA - Canada 72
RU - Federazione Russa 60
JP - Giappone 57
IQ - Iraq 42
MX - Messico 39
AR - Argentina 38
AT - Austria 34
NL - Olanda 26
SA - Arabia Saudita 25
ZA - Sudafrica 23
KR - Corea 22
TR - Turchia 22
ES - Italia 17
BE - Belgio 16
CI - Costa d'Avorio 16
PK - Pakistan 15
VE - Venezuela 14
IR - Iran 11
PH - Filippine 11
LT - Lituania 10
PE - Perù 10
UZ - Uzbekistan 10
AU - Australia 9
CL - Cile 9
EC - Ecuador 9
JM - Giamaica 9
KE - Kenya 9
MA - Marocco 9
TH - Thailandia 9
CH - Svizzera 8
HU - Ungheria 8
MY - Malesia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
DZ - Algeria 7
TN - Tunisia 7
CO - Colombia 6
UY - Uruguay 6
CR - Costa Rica 5
KZ - Kazakistan 5
LV - Lettonia 5
OM - Oman 5
RO - Romania 5
AL - Albania 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
EG - Egitto 4
GT - Guatemala 4
JO - Giordania 4
NP - Nepal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
EE - Estonia 3
HN - Honduras 3
MK - Macedonia 3
NI - Nicaragua 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AD - Andorra 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
MM - Myanmar 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
TW - Taiwan 2
TZ - Tanzania 2
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BT - Bhutan 1
BZ - Belize 1
CG - Congo 1
DM - Dominica 1
Totale 11.952
Salva come PNG Salva come JPEG
Città #
Singapore 1.058
Chandler 485
Ashburn 451
San Jose 427
Dallas 180
Rome 141
Beijing 135
Dublin 123
New York 112
Los Angeles 100
Wilmington 94
Warsaw 91
Jacksonville 86
Milan 86
San Mateo 86
Fairfield 80
Ho Chi Minh City 79
Jakarta 79
Munich 76
Lauterbourg 70
Hong Kong 69
Ann Arbor 66
Hanoi 63
Houston 63
Hefei 62
Boston 61
Cattolica 61
Dearborn 61
Nanjing 61
Woodbridge 56
Frankfurt am Main 47
Seattle 47
Tokyo 47
Chicago 46
Atlanta 45
São Paulo 44
Marseille 39
Moscow 39
Princeton 38
The Dalles 37
Council Bluffs 35
Hyderabad 33
Redwood City 32
Santa Clara 31
Orem 29
Boardman 28
Helsinki 27
Buffalo 26
Detroit 26
Lawrence 26
Nürnberg 25
Toronto 25
Kraków 23
Redmond 23
Nanchang 22
Nuremberg 22
Bologna 21
Brooklyn 21
Cambridge 20
Hangzhou 20
London 19
Mexico City 18
Montreal 18
Paris 18
Phoenix 18
St Louis 18
Hebei 17
Seoul 17
Washington 17
Abidjan 16
Brussels 16
Belo Horizonte 15
Kent 15
San Francisco 15
Vienna 15
Guangzhou 14
Leawood 14
Norwalk 14
Da Nang 12
Memphis 12
Tianjin 12
Baghdad 11
Chennai 11
Florence 11
Johannesburg 11
Lappeenranta 11
Las Vegas 11
Shanghai 11
Stockholm 11
Changsha 10
Dhaka 10
Düsseldorf 10
Ealing 10
Tashkent 10
Bremen 9
Buenos Aires 9
Denver 9
Mountain View 9
North Bergen 9
Rio de Janeiro 9
Totale 6.128
Salva come PNG Salva come JPEG
Nome #
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 452
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 373
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 331
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 320
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 317
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 299
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 246
G20210A protrombin gene variant and clinical outcome in patients with a first acute coronary syndrome 245
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 243
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 237
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 232
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 204
Risk factor and etiology analysis of ischemic stroke in young adult patients 201
High Frequency of Germline ATM Variants in Familial Philadelphia-Negative Myeloproliferative Neoplasms 194
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial 191
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 178
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 174
Venous thromboembolism in multiple myeloma 173
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 170
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 168
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 167
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 165
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 163
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 158
Contractile reserve of dysfunctional myocardium after revascularization: A dobutamine stress echocardiography study 158
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 155
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 153
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 152
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 152
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 150
Assessment of congenital neutropenia in children: common clinical sceneries and clues for management 148
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls 146
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 144
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 142
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 138
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 136
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 134
Inherited thrombophilia: treatment during pregnancy. 132
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 130
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 130
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 128
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 127
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients 121
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population 120
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 120
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 119
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 119
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 116
Cerebral sinus-venous thrombosis 112
Isolated light chain deposition disease neuropathy in a patient with multiple myeloma 111
Reassessment of contractile reserve after revascularization of akinetic myocardium 111
Coagulopathy in CAR-T: Critical concern or mere blip? 109
Predicting Factors for Seizures after Cerebral Venous Thrombosis: A Retrospective Single Center Cohort Study 108
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial 107
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 107
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 105
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms 105
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases 105
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years 101
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: A case-control study 101
Predicting Factors for Seizures after Cerebral Venous Thrombosis: A Retrospective Single Center Cohort Study 100
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 99
Structural analysis of protein Z gene variants in patients with foetal losses 98
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study 92
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 92
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls 92
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 92
Real-world use of thrombopoietin receptor agonists in elderly patients with primary immune thrombocytopenia 92
Glycoprotein la C807T qene polymorphism and increased risk of recurrent acute coronary syndromes: A five year follow up 91
Venous thromboembolism in patients with liver diseases 90
Risk factor and etiology analysis of ischemic stroke in young adult patients 88
Venous thromboembolism in patients with liver diseases 88
Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis? 88
G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome 86
Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: An expert consensus 82
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases 80
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms 74
Second cancers in MPN: Survival analysis from an international study 73
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis 67
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera 64
Left atrial myxoma supplied from the right coronary artery 60
Glycoprotein IA C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow up. 58
ROLE OF 18 F-FDG PET/CT IN THE ASSESSMENT OF PATIENTS WITH SMOLDERING MULTIPLE MYELOMA 57
The impact of daratumumab-containing induction on stem cell mobilization, collection and engraftment in newly diagnosed multiple myeloma: results of the prospective DILEMMA study 27
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study 19
TP53 Mutations Unfavorably Impact the Outcomes of Myelofibrosis Patients with or Without Hematopoietic Stem Cell Transplantation: A Single-Center Study and Meta-Analysis 15
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea 15
The risk of thrombosis in patients with acute leukemia: Occurrence of thrombosis at diagnosis and during treatment 4
Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome 1
Totale 12.137
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.695
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022622 0 35 16 40 32 13 20 80 45 45 121 175
2022/20231.356 203 197 115 199 77 159 79 84 154 25 35 29
2023/2024742 28 177 30 52 34 127 37 40 14 31 80 92
2024/20251.552 26 67 91 62 121 37 59 71 254 165 325 274
2025/20264.490 601 120 319 416 916 191 705 216 281 293 212 220
2026/20271.363 213 1.150 0 0 0 0 0 0 0 0 0 0
Totale 12.137